The circulating tumor cell (CTC) diagnostics market is projected to reach US$ 3,656.38 million by 2028 from US$ 1,909.41 million in 2021; it is estimated to grow at a CAGR of 9.7% from 2021 to 2028.
Circulating tumor cells (CTCs) have tremendous potential in diagnosing and treating cancer. Many techniques have been developed and are under continuous improvement to enhance their efficacy of CTC detection, isolation, enrichment, and analysis. Mostly used approach for CTC detection and isolation is immune-based detection, whereby antibodies selectively bind cell surface antigens. Tumor cells express different cell surface markers than blood cells and are separated from the circulatory cells. CTCs help detect minor subgroups of cells present in the primary tissue, which might eventually cause treatment resistance or relapse of the disease. Hence, detecting and characterizing CTCs can become an inevitable step in treating solid tumor malignancies.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Circulating Tumor Cell (CTC) Diagnostics Market: Strategic Insights
Market Size Value in US$ 1,909.41 million in 2021 Market Size Value by US$ 3,656.38 million by 2028 Growth rate CAGR of 9.7% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Circulating Tumor Cell (CTC) Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 1,909.41 million in 2021 |
| Market Size Value by | US$ 3,656.38 million by 2028 |
| Growth rate | CAGR of 9.7% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The circulating tumor cell (CTC) diagnostics market is segmented on the basis of technology, application, end-user, and geography. The market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the globally leading market players.
Lucrative Regions for Circulating Tumor Cell (CTC) Diagnostics Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Demand for Minimally Invasive Diagnostic Procedures to Drive Circulating Tumor Cell (CTC) Diagnostics Market Growth during Forecast Period
There is a growing preference for minimally invasive or noninvasive procedures among patients for diagnostic purposes. Early cancer detection, mutation detection, tumor monitoring throughout treatment, and recurrence monitoring are possible using circulating tumor cell diagnostics, which uses a noninvasive method. Researchers can trace all epigenetic and genetic changes in solid tumors using blood samples with circulating tumor cells. Patients are at a lesser risk with these tests, and clinicians can readily perform them multiple times. Patients prefer minimally invasive procedures because the advanced instruments used in such procedures allow for more delicate and complex work to be performed with lower risk, less pain, and less scarring.
Due to technological advancements in feasibility and processing times, circulating tumor cell diagnostics and liquid biopsy have recently attracted considerable interest as a noninvasive alternative to tissue biopsy in cancer patients. Liquid biopsy adoption will be aided by an increased understanding of improved minimally invasive cancer detection technologies. The market growth will be influenced by rising demand for noninvasive tools and laboratory acceptance of CTCs tests and liquid biopsy. A liquid biopsy is a noninvasive and simple alternative to surgical biopsies that allows doctors to discover a range of information about tumors from a simple blood sample. Blood tests are painless, noninvasive, bear no risks, and cut down the cost and time to diagnose a problem. In addition, CTCs, cfDNAs, exosomes, and microvesicles can be detected in a blood sample, making blood-based liquid biopsies more popular. Thus, the increased demand for minimally invasive diagnostic tests is spurring the market growth.
Technology Insights
Based on technology, the global circulating tumor cell (CTC) diagnostics market is segmented into CTC detection and enrichment method, CTC direct detection methods, and CTC analysis. In 2020, the CTC detection and enrichment segment held the largest share of the market. Moreover, the same segment is expected to register the highest CAGR in the market during 2021–2028. With the help of CTC diagnostics, individuals can be diagnosed early. Therefore, the adaption of these technologies is increasing, which is expected to drive the market during the forecast period.
Application Insights
Based on application, the global circulating tumor cell (CTC) diagnostics market is bifurcated into clinical/liquid biopsy and research. In 2020, the research segment held a larger share of the market and the same segment is expected to register a higher CAGR in the market during 2021–2028. Owing to the rise in the detection and diagnosis of various medical conditions across the globe, the market is expected to grow in the future.
End-User Insights
Based on end-users, the circulating tumor cell (CTC) diagnostics market is segmented into hospital and clinics, research and academic institutes, and diagnostic centers. The research and academic institutes segment held the largest market share in 2021 and is expected to register the highest CAGR in the market during the forecast period. The increasing research on cancer diagnosis and therapeutic development, growing awareness related to cancer diagnosis, and high investment from government and other enterprises are a few of the critical factors supporting the market growth for the Research and Academic Institutes segment.
Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product launches, and mergers and acquisitions are highly adopted strategies by the global circulating tumor cell (CTC) diagnostics market players. A few of the recent key market developments are listed below:
- In January 2022, Thermo Fisher Scientific Inc. announced the complete acquisition of PeproTech for a total cash purchase price of approx. US$ 1.85 billion.
- In December 2021, Epic Sciences, Inc. announced the launch of DefineMBC, a novel metastatic breast cancer (MBC) test that includes both cell-based and cell-free analysis from a single blood draw.
The COVID-19 pandemic had a negative impact on the people suffering from cancer and cancer surveillance capacities. Also, due to the pandemic, reduced resources and availability to care made cancer detection and treatment difficult, resulting in higher mortality, and lower survival. Due to a compromised immune system caused by cancer and/or its treatment, cancer patients are susceptible to infectious pathogens (e.g., surgery and chemotherapy). This has raised fears that COVID-19 problems and mortality may be common in cancer patients. Thus, the pandemic negatively impacts the circulating tumor cell (CTC) diagnostics market.
Circulating Tumor Cell (CTC) Diagnostics – Market Segmentation
The global circulating tumor cell (CTC) diagnostics market is segmented on the basis of technology, application, end-user, and geography. In terms of technology, the market is segmented into CTC detection and enrichment method, CTC direct detection methods, and CTC analysis. Based on application, the global circulating tumor cell (CTC) diagnostics market is bifurcated into clinical/liquid biopsy and research. Based on end-users, the circulating tumor cell (CTC) diagnostics market is segmented into hospital and clinics, research and academic institutes, and diagnostic centers. The market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.
Company Profiles
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc0
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global circulating tumor cell (CTC) diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the factors such as most foreign companies in the healthcare sector have R&D centres in the United States. Moreover, the increase in prevalence of cancer in the country along with various organic and inorganic developments done by the companies. And, Asia Pacific is the fastest-growing region growing at the CAGR of 10.3% during the forecast period.
The circulating tumor cell (CTC) diagnostics market majorly consists of the players such as Thermo Fisher Scientific, Stemcell Technologies, Inc, QIAGEN, Precision Medicine Group, LLC, Advanced Cell Diagnostics (Bio-Techne Corporation), Epic Lifesciences, Screencell, Ikonisys, Inc, IV Diagnostics, Fluxion Biosciences, among others
The research segment dominated the global circulating tumor cell (CTC) diagnostics market and accounted for the largest revenue share of 67.65% in 2021.
The CTC detection and enrichment method segment dominated the global circulating tumor cell (CTC) diagnostics market and held the largest revenue share of 62.85% in 2021.
Key factors that are driving the growth of this market are increasing prevalence of cancer across the globe along with rising demand for minimally invasive diagnostic procedures.
A Circulating Tumor Cell (CTC) is a cell that shed into lymphatics from the primary tumor and carried out throughout the body with blood circulation. Circulating tumor cells are the seeds for growth and metastases for additional tumors in distant organs and is responsible for majority of cancer related deaths. The diagnosis, detection and analysis of CTC can assist in patients’ prognoses determine appropriate tailored treatments for the patients. The CTC diagnosis has a lot of advantages for traditional diagnostic procedures. The advantages of CTC detection include, it is non-invasive, effective and can be used repeatedly. The CTC detection and enrichment, CTC direct detection and CTC analysis are the technologies used for CTC detection.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Technology
1.3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Application
1.3.3 Global Circulating Tumor Cell (CTC) Diagnostics Market – By End-User
1.3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer Globally
5.1.2 Rising Demand for Minimally Invasive Diagnostic Procedures
5.2 Market Restraints
5.2.1 Rising Dearth of Skilled Professionals Performing Diagnostic Procedures
5.3 Market Opportunities
5.3.1 Untapped Potential of Emerging Economies
5.4 Future Trends
5.4.1 Technological Advancements in Isolation of Circulating Tumor Cell
5.5 Impact Analysis
6. Circulating Tumor Cell (CTC) Diagnostics Market– Global Analysis
6.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis
6.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – Technology
7.1 Overview
7.2 Global Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2021 & 2028 (%)
7.3 CTC detection and Enrichment Method
7.3.1 Overview
7.3.2 CTC detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 CTC Direct Detection Method
7.4.1 Overview
7.4.2 CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 CTC Analysis
7.5.1 Overview
7.5.2 CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application - 2021 & 2028 (%)
8.3 Clinical/Liquid Biopsy
8.3.1 Overview
8.3.2 Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 Risk Assessment
8.3.3.1 Overview
8.3.3.2 Risk Assessment : Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Screening and Monitoring
8.3.4.1 Overview
8.3.4.2 Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Research
8.4.1 Overview
8.4.2 Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Cancer Stem Cell & Tumorigenesis Research
8.4.2.1.1 Overview
8.4.2.1.2 Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Drug/Therapy Development
8.4.2.2.1 Overview
8.4.2.2.2 Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 – End user
9.1 Overview
9.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Research and Academic Institutes
9.4.1 Overview
9.4.2 Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Centers
9.5.1 Overview
9.5.2 Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. Global Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis
10.1 North America: Circulating Tumor Cell (CTC) Diagnostics Market
10.1.1 Overview
10.1.2 North America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.4 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.4.1 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.4.2 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.5 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.6.1.4 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.4.1 US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.6.1.4.2 US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.6.1.5 US: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.7 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.1.1 Overview
10.1.7.1.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.1.3 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.7.1.4 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.7.1.4.1 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.7.1.4.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.7.1.5 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.7.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.2.1 Overview
10.1.7.2.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.2.3 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.7.2.4 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.7.2.4.1 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.7.2.4.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.7.2.5 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market
10.2.1 Overview
10.2.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.4.1 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.2.4.2 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)
10.2.5 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4.1 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.2.6.1.4.2 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.2.6.1.5 Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4.1 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.2.6.2.4.2 France: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)
10.2.6.2.5 France: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4.1 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.2.6.3.4.2 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.2.6.3.5 UK: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4.1 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.2.6.4.4.2 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.2.6.4.5 Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4.1 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.2.6.5.4.2 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.2.6.5.5 Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4.1 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.2.6.6.4.2 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.4.1 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.4.2 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.1.3 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.1.3.1 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.1.3.2 China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.1.4 China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.2.3 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.2.3.1 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.2.3.2 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.2.4 Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6.3 India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.3.3 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.3.3.1 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.3.3.2 India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.3.4 India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.4.3 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.4.3.1 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.4.3.2 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.4.4 Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6.5 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.5.3 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.5.3.1 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.5.3.2 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.5.4 South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (USD Million)
10.3.6.6.3.2 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (USD Million)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.3 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.4 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
10.4.4.1 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.4.4.2 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.4.5 Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
10.4.6.1 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.1.3 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.1.4 UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.1.4.1 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.4.6.1.4.2 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)
10.4.6.1.5 UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.2.4 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.2.4.1 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.4.6.2.4.2 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)
10.4.6.2.5 Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.3.3 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.3.4 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.3.4.1 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.4.6.3.4.2 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)
10.4.6.3.5 South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028, By Application (US$ Million)
10.4.6.4.4.1 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application , 2019–2028 (US$ Million)
10.4.6.4.4.2 Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market
10.5.1 Overview
10.5.2 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.5.4 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.5.4.1 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
10.5.4.2 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4.1 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.4.2 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.5 Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4.1 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.4.2 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.5 Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4.1 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4.2 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Global Circulating Tumor Cell (CTC) Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 STEMCELL Technologies Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Precision Medicine Group, LLC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 EPIC SCIENCES, INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SCREENCELL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 IKONISYS, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 IVDiagnostics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 FLUXION BIOSCIENCES
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 33. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 34. France: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. France: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 37. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 38. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 39. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. UK: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 61. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 62. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 63. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 64. China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 65. China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 71. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 72. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application– Revenue and Forecast to 2028 (USD Million)
Table 73. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/ Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 74. India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research– Revenue and Forecast to 2028 (USD Million)
Table 75. India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User– Revenue and Forecast to 2028 (USD Million)
Table 76. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 77. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 78. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 79. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 80. Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 81. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 82. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 83. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 84. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 85. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 92. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 93. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 94. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 95. Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 96. UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 97. UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 98. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 99. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 100. UAE: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 101. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 102. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 103. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 104. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 105. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 106. South Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 107. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 108. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 109. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 110. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 111. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 112. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 113. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 114. Rest of Middle East & Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application – Revenue and Forecast to 2028 (US$ Million)
Table 115. Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 116. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 117. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 118. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
Table 119. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
Table 120. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
Table 121. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 122. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 123. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
Table 124. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
Table 125. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
Table 126. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 127. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 128. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
Table 129. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
Table 130. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
Table 131. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 132. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)
Table 136. Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
Table 137. Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
Table 138. Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market
LIST OF FIGURES
Figure 1. Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
Figure 2. Circulating Tumor Cell (CTC) Diagnostics Market, By Region
Figure 3. Global Circulating Tumor Cell (CTC) Diagnostics Market Overview
Figure 4. CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Circulating Tumor Cell (CTC) Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Circulating Tumor Cell (CTC) Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 17. Market Positioning of Key Players in Global Circulating Tumor Cell (CTC) Diagnostics Market
Figure 18. Global Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2021 & 2028 (%)
Figure 19. CTC detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Segment - 2021 & 2028 (%)
Figure 23. Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2021 & 2028 (%)
Figure 30. Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 34. North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 36. US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 40. Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42. Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 49. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 50. Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 51. China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 58. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 59. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 60. UAE: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. Saudi Arabia: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. South Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. Rest of Middle East and Africa: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 64. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 65. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 66. South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 67. Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Impact of COVID-19 Pandemic in North American Country Markets
Figure 71. Impact of COVID-19 Pandemic in European Country Markets
Figure 72. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 73. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 74. Impact of COVID-19 Pandemic in SCAM Country Markets
Figure 75. Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
The List of Companies - Circulating Tumor Cell (CTC) Diagnostics Market
- Thermo Fisher Scientific Inc.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC.
- Advanced Cell Diagnostics, Inc. (BIO-TECHNE CORPORATION)
- Epic Sciences
- ScreenCell
- Ikonisys, Inc.
- IVDiagnostics
- Fluxion Biosciences Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Circulating Tumor Cell (CTC) Diagnostics Market
Jan 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jan 2022